Our dispensaries are in Canada, U.S., United Kingdom, New Zealand, Mauritius, and Australia
Subcutaneous administration (which bypasses first-pass metabolism and delivers more peptide to target tissues) was not extensively tested in human trials, and this route is what most current research protocols use
All GLP-1s are clinically-tested, stimulant-free, and non-habit forming
A responsible plan may include adequate protein intake, resistance training, walking or other appropriate activity, body composition tracking when available, lab monitoring, gradual dose escalation when appropriate, nutrition support during appetite reduction, hydration and electrolyte guidance, monitoring fatigue or excessive appetite suppression, and evaluation for hormone, thyroid, or nutrient issues when relevant
Medically reviewed on May 13, 2026 7 Sources Have thoughts or suggestions about this article
doi:10.1002/jcph.443 158